Influvac Tetra Vaccine

Influvac Tetra Vaccine contains influenza vaccine as its active component. It is designed to prevent infection with the influenza virus. In individuals who become infected despite vaccination, the vaccine may reduce the severity of symptoms and shorten the duration of illness. Influenza poses particular risks for elderly patients, young children, pregnant women, and patients with certain chronic health conditions. Vaccination of these populations can help prevent severe complications and reduce the risk of hospitalisation or death. Higher vaccination coverage in communities can reduce transmission of influenza. Some patients may have allergies to vaccine components, including eggs or other ingredients, and may require specific precautions. Patients who have experienced a severe allergic reaction to a previous dose of Influvac Tetra Vaccine should not receive further doses. Patients with a history of Guillain-Barré syndrome should consult their healthcare provider before receiving this vaccine, as an association between GBS and this vaccine has been reported. Patients with kidney disease can receive the Influvac injection safely. The vaccine is recommended for older adults, who face higher risk of severe influenza complications.

Influvac tetra Vaccine uses: Prevention of Influenza.

The influvac Tetra vaccine stimulates the body's immune system to produce an immune response against specific influenza virus strains. Once administered, the inj influvac tetra introduces inactivated or weakened forms of the virus or specific viral proteins to trigger the production of antibodies. These antibodies then recognize and bind to the influenza virus if the body is exposed to it in the future.

Influvac tetra Vaccine causes some side effects like all medications, although not everyone will experience them. Serious Severe allergic reactions (extremely rare) Common Soreness, redness, or swelling at the influvac tetra injection site Low-grade fever Muscle aches and fatigue

Inform healthcare providers about any history of severe allergic reactions, especially to previous Influvac tetra Vaccine or vaccine components, a history of Guillain-Barré Syndrome, or severe egg allergies. It is essential to disclose any ongoing medications or treatments. Consulting a healthcare provider before vaccination is recommended for individuals with certain neurological conditions, pregnant or breastfeeding women, or those with specific medical conditions. Additionally, considering the appropriate vaccine type based on age and the severity of current illness is important to ensure the safe administration of the vaccine.